Gene Therapy Weekly
Susan Hasty, Publisher
Table of Contents . . . February 20th, 1995
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Conference Coverage - Clinical Trial of Transdominant Rev Underway
Neurology - Alternative Strategy for Particle-Mediated Gene Transfer
Blood Banking - Unseparated Freezing of Cord Blood Best for CD34 Enrichment
Cancer/Gene Therapy - Genetics Pave a New Path Towards Cancer Therapies
Conference Coverage - Compound Represents New Approach to Anti-HIV Drugs
Diagnostics - Increased Frequency of bcl-2 Oncogene Translocation in Heavy Smokers
Endocrinology - Prostate-Specific Antigen, Not Just a Guy Thing
Factor XI Deficiency - Mutation Causing Factor XI Deficiency Found in Population Group
Glanzmann's Thrombasthenia - Gene Mutation Associated with Bleeding Disorder
Hematopoietic Cells - Human Umbilical Cord Blood May Be Source for Gene Delivery
Hematopoietic/Progenitor Cells - AAV Vector System May Enable Transduction of Stem Cells
Industry News/Acquisition - Company Expands into DNA Analysis Market
Industry News/Clinical Trials - Company Announces Results with Antisense Oligonucleotides
Industry News/NSCLC - Injection of Normal p53 Results in Tumor Suppression
Leishmaniasis - Naked DNA of Cytokines Feasible for Vaccine
Pediatrics/Anemia - DNA Technology Used for Treatment in Premature Infants
Drug Development - Pharmacokinetics - "In Vivo Stability and Pharmacokinetics of an Anti-HIV Antisense Oligonucleotide Phosphorothioate (GEM 91) in Rats and HIV Infected Individuals."
Immunology - Gene Therapy - "Universal Base Analogs in Antisense Oligodeoxinucleotides (AS ODNs): A Therapeutic Strategy Against HIV Variability."
Immunology - Stem Cells - "Pluripotent CD34+ Stem Cells are not Susceptible to HIV Infection."
Therapy - Gene Targets - "Human Bone Marrow Derived CD34+ Cells as Targets for Gene Therapy against HIV Infection."
Therapy - Gene Therapy Vectors - "Generation of HIV Containing the HTLV-I LTR Tax-Responsive Elements in Place of the LTR Enhancer Results in Selective Tropism and Cytotoxicity for HTLV-I Infected Cells."
Therapy - Gene Therapy/HIV - "Gene Therapy for Human Immunodeficiency Virus Infection: Combination of Anti-HIV-1-Rev sFV and Ribozyme to the HIV-1 RRE."
Therapy - HIV - "Adoptive Transfer of Genetically Modified Cells in Identical Twins Discordant for HIV-1 Infection."
Therapy - HIV - "Sensitivity to Protease Inhibitors of Recombinant HIV's with Defined Mutations in the Protease Gene."
Bone Marrow - Hematopoietic Progenitors - "Progress in the Ex Vivo Expansion of Hematopoietic Progenitors."
Endocrinology - Lutropin and Follitropin - "Secretion of Lutropin and Follitropin from Transfected GH(3) Cells: Evidence for Separate Secretory Pathways."
Virology - HIV-1 Molecular Clones - "Construction of Infectious Molecular Clones of HIV-1 Containing Defined Mutations in the Protease Gene."
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
